from PR Newswire
from PR Newswire
from PR Newswire
Orexigen(R) Therapeutics Names Michael Scaife Senior Vice President of Regulatory Affairs and Product Development, Contrave(R) Program
April 27, 2009
from PR Newswire
Orexigen(R) Therapeutics Names Michael Narachi, 24-Year Biopharmaceutical Veteran, New President and Chief Executive Officer
March 31, 2009
from PR Newswire
Investing in the Biotech Sector: 5 Elements To Consider
March 31, 2009
When Arena Pharmaceuticals (Nasdaq: ARNA ) released positive Phase III data on its obesity drug, Lorcaserin, many people expected shares to take off. After all, the company’s press release on Monday... Read More
from Jutia Group
from PR Newswire
Orexigen Therapeutics (OREX) Tops Q4 View By 5c
March 12, 2009
OREXIGEN(R) Therapeutics Announces Fourth Quarter and Year Ended December 31, 2008 Financial Results
March 12, 2009
from PR Newswire
from PR Newswire
from PR Newswire
Orexigen(R) Therapeutics to Speak at BIO CEO & Investor Conference
February 04, 2009
from PR Newswire
from ACCESSWIRE
A Calendar of Expected Clinical Trial Results (OREX, rated BUY)
January 11, 2009
A Calendar of Expected Clinical Trial Results The accompanying table [click to enlarge] includes 58 entries of expected clinical trial results in addition to pending FDA applications for new product... Read More
category
Healthcare
,
Biotechnology & Drugs
Surging Unemployment Sends Markets Tumbling
January 09, 2009
A surge in the nation's unemployment rate sent the markets tumbling during the midday with the Dow plunging 108 points to 8635. Nasdaq plummeted 33 points to 1584. Read More
category
Market News
Unusual 11 Mid-Day Movers 1/9: PALM, HWAY, RAMS, AMMD Higher; RGN, WSCI, RMBS, OREX Lower
January 09, 2009
Orexigen(R) Therapeutics (OREX) Announces 1st of 4 Phase 3 Trials of Contrave(R) Met Co-Primary and Key Secondary Endpoints
January 08, 2009
Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints
January 08, 2009
from PR Newswire
from PR Newswire
from PR Newswire
Orexigen(R) Therapeutics to Speak at RBC Capital Markets Investor Conference Panel
December 08, 2008
from PR Newswire
Orexigen Therapeutics Halts Drug Trials
December 05, 2008
Soaring Unemployment Weighs Down Markets
December 05, 2008
Soaring unemployment sparked fears of an even deeper and prolonged recession sending the markets lower during the midday with the Dow tumbling 90 points to 8286. Nasdaq fell 6 points to 1439. Read More
category
Market News
Orexigen(R) Therapeutics Announces Changes to Its Clinical Programs and Management Team
December 05, 2008
from PR Newswire
Orexigen (OREX) CEO/President to Take Leave of Absence; Names Weber as Interim Replacement
November 10, 2008
Orexigen(R) Therapeutics Names Eckard Weber Executive Chairman and Interim Chief Executive Officer
November 10, 2008
from PR Newswire
Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results
November 06, 2008
from PR Newswire
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here